BR0007255A - Derivados carbamato de diaril 1,3,4-oxadiazolona - Google Patents

Derivados carbamato de diaril 1,3,4-oxadiazolona

Info

Publication number
BR0007255A
BR0007255A BR0007255-9A BR0007255A BR0007255A BR 0007255 A BR0007255 A BR 0007255A BR 0007255 A BR0007255 A BR 0007255A BR 0007255 A BR0007255 A BR 0007255A
Authority
BR
Brazil
Prior art keywords
oxadiazolone
carbamate derivatives
diaryl
derivatives
solvate
Prior art date
Application number
BR0007255-9A
Other languages
English (en)
Inventor
Piyasena Hewawasam
Xi Chen
John E Starret
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BR0007255A publication Critical patent/BR0007255A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"DERIVADOS CARBAMATO DE DIARIL 1,3,4-OXADIAZOLONA" A invenção presente fornece derivados novos de carbamato oxadiazolona tendo a fórmula geral onde R¹ a R² são como definido aqui, ou um sal não tóxico farmacêuticamente aceitável ou solvato do mesmo e são úteis no tratamento de desordens que são responsivas à abertura de canais de potássio ativados por cálcio de larga condutância.
BR0007255-9A 1999-01-29 2000-01-20 Derivados carbamato de diaril 1,3,4-oxadiazolona BR0007255A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11791399P 1999-01-29 1999-01-29

Publications (1)

Publication Number Publication Date
BR0007255A true BR0007255A (pt) 2001-09-25

Family

ID=22375485

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007255-9A BR0007255A (pt) 1999-01-29 2000-01-20 Derivados carbamato de diaril 1,3,4-oxadiazolona

Country Status (18)

Country Link
US (1) US6162817A (pt)
EP (1) EP1150978A4 (pt)
JP (1) JP2002535402A (pt)
KR (1) KR20010101869A (pt)
CN (1) CN1133636C (pt)
AU (1) AU771471B2 (pt)
BR (1) BR0007255A (pt)
CA (1) CA2358964A1 (pt)
CZ (1) CZ20012712A3 (pt)
HU (1) HUP0200089A3 (pt)
ID (1) ID29269A (pt)
IL (1) IL144540A0 (pt)
NO (1) NO20013715L (pt)
NZ (1) NZ512077A (pt)
PL (1) PL349097A1 (pt)
TR (1) TR200102070T2 (pt)
WO (1) WO2000044745A1 (pt)
ZA (1) ZA200104304B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297241B1 (en) * 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
HUP0303559A3 (en) * 2000-10-13 2006-02-28 Bristol Myers Squibb Co Selective maxi-k-potassium channel openers functional under conditions of high intracellular calcium concentration and uses thereof
CA2708281A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583213A5 (pt) * 1973-05-21 1976-12-31 Ciba Geigy Ag
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
AU735704B2 (en) * 1998-01-29 2001-07-12 Bristol-Myers Squibb Company Derivatives of 1,3,4-oxadiazolone
PT1056754E (pt) * 1998-01-29 2004-03-31 Bristol Myers Squibb Co Derivados fosfatados de 1,3,4-oxadiazolona de diarilo
AU736712B2 (en) * 1998-01-29 2001-08-02 Bristol-Myers Squibb Company Benzoate derivatives of diaryl 1,3,4-oxadiazolone
AU736599B2 (en) * 1998-01-29 2001-08-02 Bristol-Myers Squibb Company Amino acid derivatives of diaryl 1,3,4-oxadiazolone

Also Published As

Publication number Publication date
KR20010101869A (ko) 2001-11-15
EP1150978A4 (en) 2002-06-12
CA2358964A1 (en) 2000-08-03
PL349097A1 (en) 2002-07-01
NO20013715L (no) 2001-09-17
IL144540A0 (en) 2002-05-23
ZA200104304B (en) 2002-01-24
HUP0200089A3 (en) 2004-07-28
TR200102070T2 (tr) 2001-12-21
JP2002535402A (ja) 2002-10-22
NO20013715D0 (no) 2001-07-27
HUP0200089A2 (hu) 2002-05-29
CZ20012712A3 (cs) 2001-10-17
WO2000044745A1 (en) 2000-08-03
AU2970000A (en) 2000-08-18
ID29269A (id) 2001-08-16
NZ512077A (en) 2003-07-25
AU771471B2 (en) 2004-03-25
CN1336926A (zh) 2002-02-20
EP1150978A1 (en) 2001-11-07
US6162817A (en) 2000-12-19
CN1133636C (zh) 2004-01-07

Similar Documents

Publication Publication Date Title
BR9915744A (pt) Derivados 4-arilquinolin-2-ona 3-substituìdos como moduladores do canal de potássio
BR0109703A (pt) Derivados de piperazina
DE69725825D1 (de) 5-HT1F-Agonisten
BR0308737A (pt) Pró-drogas de fosfato de fluoroxindóis
ATE248837T1 (de) Chinuclidin-acrylamide
EA200400536A1 (ru) Макролиды
NO971471L (no) Nye karboksamider med fungicid aktivitet
PT718293E (pt) Composto ciclodepsipeptidico
TNSN01012A1 (fr) Derives amines de dihydro-1, 3,5-triazine et leurs applications en therapeutique
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
ATE299871T1 (de) Neue zyklische depsipeptid pf1022 derivate
BR0117123A (pt) Dispositivo de retenção gástrica expansìvel
BR9913010A (pt) Composto, composição farmacêutica, e, processo para o tratamento de distúrbios responsivos à abertura dos canais de potássico ativado por cálcio de grande condutância em um mamìfero em sua necessidade.
ATE252590T1 (de) Phosphorylierte derivate des diaryl 1,3,4 oxadiazolon
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
EA200000016A1 (ru) Гидроксициклопентанон
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
NO20000519L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.